专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20170247308A1 NOVEL CANNABIGEROL DERIVATIVES 有权
公开(公告)号：US20170247308A1
公开(公告)日：2017-08-31
申请号：US15122160
申请日：2015-02-12
申请人： VIVACELL BIOTECHNOLOGY ESPAÑA, S.L
发明人： Giovanni APPENDINO , María Luz BELLIDO CABELLO DE ALBA , Eduardo MUÑOZ BLANCO
IPC分类号： C07C50/28 , A61K31/122 , C07C225/28 , A61K31/13 , C07C69/757 , A61K31/215
CPC分类号： C07C50/28 , A61K31/122 , A61K31/13 , A61K31/215 , C07C69/757 , C07C69/95 , C07C225/28 , C07C2601/14 , C07C2601/16
摘要： The present invention relates to novel cannabigerol quinone derivatives of formula (I) wherein R is the carbon atom of a linear or branched group, represented by: aryl, alkenyl, alkynyl or alcoxycarbonil groups; or wherein R is the nitrogen atom of a linear or branched group, represented by: alkylamino, arylamino, alkenylamino or alkynylamino groups; or, alternatively, R represents a bond between 2 molecules of formula (I) forming a dimer. The invention also relates to the use of any of the compounds of formula (I) as medicaments in therapy, particularly for treating PPARg-related diseases due to their high PPARg agonistic effect lacking electrophilic (Nrf2 activation) and cytotoxic activities. This invention also provides pharmaceutical compositions comprising said compounds and method of treating diseases with said compounds.

2. 发明申请

US20170044092A1 NOVEL CANNABIDIOL QUINONE DERIVATIVES 有权
标题翻译：新型CANNABIDIOL喹诺酮衍生物
公开(公告)号：US20170044092A1
公开(公告)日：2017-02-16
申请号：US15304810
申请日：2014-04-16
申请人： VIVACELL BIOTECHNOLOGY ESPAÑA S.L.
发明人： Giovanni APPENDINO , María Luz BELLIDO CABELLO DE ALBA , Eduardo MUÑOZ BLANCO
IPC分类号： C07C225/28 , C07C69/95
CPC分类号： C07C225/28 , C07B2200/07 , C07C69/95 , C07C2601/16 , C07C2602/42
摘要： The present invention relates to novel cannabidiol quinone derivatives of formula (I) (I) wherein R is the carbon atom of a, linear or branched group, represented by: alkyl, aryl, alkenyl, alkynyl, acyl or alkoxycarbonyl groups; or wherein R is the nitrogen atom of a, linear or branched group represented by: alkylamine, arylamine, alkenylamine or alkynylamine groups. The invention also relates to the use of any of the compounds of formula (I) as medicamentsin therapy, particularly for treating diseases and conditions responsive to PPARg modulation due to their high PPARg agonistic effect lacking electrophilic (Nrf2 activation) and cytotoxic activities. This invention also provides pharmaceutical compositions comprising said compounds and method of treating diseases with said compounds.
摘要翻译：本发明涉及式（I）（I）的新型大二酚醌衍生物，其中R是直链或支链基团的碳原子，由烷基，芳基，烯基，炔基，酰基或烷氧基羰基表示; 或其中R为由烷基胺，芳基胺，链烯基胺或炔基胺基团表示的直链或支链基团的氮原子。本发明还涉及任何式（I）化合物作为治疗药物的用途，特别是用于治疗由于其不具有亲电子（Nrf2活化）和细胞毒活性的高PPARg激动作用而对PPARg调节有反应的疾病和病症。本发明还提供包含所述化合物的药物组合物和用所述化合物治疗疾病的方法。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式